===== AI Summary =====
For male patients with asthenozoospermia undergoing IVF treatment in China, the primary technique used is intracytoplasmic sperm injection (ICSI). This technique selects a single sperm with relatively better morphology and motility and injects it into the egg to achieve fertilization, effectively overcoming fertilization barriers caused by low sperm motility and low count. It is suitable for patients with moderate to severe oligoasthenozoospermia, teratozoospermia, and those with a history of failed natural fertilization. The treatment process includes pre-operative examinations, ovarian stimulation, egg and sperm retrieval, ICSI fertilization, embryo culture, and transfer. A complete cycle takes about 2-3 months. Success rates depend on sperm quality, female age, egg quality, and laboratory conditions. It is recommended to choose a reproductive center with mature ICSI technology.
===== Main Content Begins =====
1. A Real Consultation Scenario: Starting from a Semen Analysis Report
"Doctor, my husband has been diagnosed with severe asthenozoospermia, with only 8% progressively motile sperm. After consulting abroad, we decided to return to China for IVF. What do you think the success rate would be in this case?" This was a cross-border consultation I encountered in the reproductive clinic. The patient was 32 years old, with an AMH of 2.3 ng/mL, and had been trying to conceive for two years without success. The male partner's three consecutive semen analyses all showed progressively motile sperm < 10%. The core question they faced was clear: Is IVF for asthenozoospermia in China feasible?
This case is not an isolated one. In daily consultations, approximately one in three male infertility patients has issues related to sperm motility or morphology. And "coming to China for IVF" is becoming an increasingly popular choice for many overseas Chinese or patients from neighboring countries – a decision influenced by multiple factors including technology, cost, language communication, and policies.
===== Module A: Direct Answer =====
2. Direct Answer: IVF for Asthenozoospermia in China is Feasible and Technologically Mature
For male asthenozoospermia, undergoing IVF treatment in China is feasible and primarily relies on Intracytoplasmic Sperm Injection (ICSI) technology. ICSI allows for the selection of a single sperm with relatively normal morphology and motility directly from the semen or testis, which is then injected into the oocyte cytoplasm using a microneedle to achieve fertilization. This process bypasses the strict requirements for sperm count, motility, and morphology needed for natural fertilization.
Currently, there are over 500 medical institutions in China with assisted reproduction qualifications, and more than 70% of reproductive centers offer ICSI technology. The level of ICSI operation and laboratory embryo culture conditions in China are now comparable to those in developed countries. In some large reproductive centers, the ICSI fertilization rate can reach 75%-85%.
Core Conclusion: As long as viable sperm with normal morphology and intact DNA are present in the patient's sperm, regardless of how low the motility is, ICSI technology offers a chance for fertilization and pregnancy. However, the specific success rate is influenced by multiple factors and requires individualized assessment.
===== Module C: Doctor's Perspective =====
3. Doctor's Perspective: The Key to IVF for Asthenozoospermia Lies in Sperm DNA Integrity
From a reproductive medicine perspective, assessing whether asthenozoospermia is suitable for IVF should not rely solely on the sperm motility parameter. As a reproductive specialist, I focus more on the following three dimensions:
- Sperm DNA Fragmentation Rate (DFI): When DFI > 30%, even if ICSI fertilization is successful, the developmental potential of the embryo decreases significantly, and the miscarriage rate increases. Therefore, DFI is a mandatory test before IVF for asthenozoospermia.
- Sperm Morphology and Acrosome Function: Although ICSI bypasses the acrosome reaction, severe sperm abnormalities (e.g., round-headed sperm) can still affect embryo quality after fertilization.
- Female Age and Egg Quality: In IVF for asthenozoospermia, the female factor often carries more weight in determining success or failure. The live birth rate with ICSI for women under 35 is approximately 45%-55%, but it drops to 15%-25% for women over 40.
In clinical decision-making, if the DFI is normal and the female ovarian function is good, the success rate of ICSI remains considerable even if sperm motility is only 5%-10%. Conversely, if the DFI is significantly elevated, etiological intervention (such as anti-infection treatment, antioxidant therapy, or varicocele surgery) should be considered before proceeding with IVF.
===== Module E: Differences Between Countries =====
4. Differences Between Countries: Characteristics of IVF for Asthenozoospermia in China
Compared with overseas countries (such as the USA, Japan, Thailand, etc.), undergoing IVF for asthenozoospermia in China has the following characteristics:
| Comparison Dimension | China (Mainland) | Overseas (USA/Japan/Thailand, etc.) |
|---|---|---|
| ICSI Technology | Mature and widespread, minimal gap with overseas | Equally mature, some centers have advantages in freezing minimal sperm |
| PGT (Preimplantation Genetic Testing) | Strict indication restrictions (e.g., chromosomal abnormalities, monogenic diseases) | Relatively broader indications, can be used for recurrent miscarriage or advanced maternal age |
| Cost (One Complete Cycle) | Approximately 30,000 - 60,000 RMB | Approximately 80,000 - 200,000 RMB (varies greatly by country) |
| Document Requirements | ID card + Marriage certificate (some centers require both partners to be present) | Passport + Visa, some countries allow single or non-married individuals |
| Language Communication | Primarily Chinese, some centers have international departments | Requires translation or English communication |
| Waiting Time | Most centers can start the cycle within 1-3 months | Appointment waiting times vary |
For patients considering "going to China for IVF," document preparation (ID card, marriage certificate, passport) and language communication are two fundamental issues that need to be confirmed in advance. Some reproductive centers in first-tier cities have international clinics that offer English services.
===== Module G: Most Easily Overlooked Details =====
5. Most Easily Overlooked Details: Four Preparations Before IVF for Asthenozoospermia
In daily consultations, I find that patients most often overlook the following four details, which directly affect the success rate of ICSI:
- Sperm DNA Fragmentation Rate Test: Many patients only undergo routine semen analysis and are unaware of the importance of DFI. Elevated DFI is a common hidden cause of embryo arrest after ICSI.
- Male Reproductive Tract Infection Screening: Chronic prostatitis, seminal vesiculitis, or epididymitis can cause oxidative stress damage to sperm, reducing ICSI success rates. It is recommended to complete prostate fluid examination, semen bacterial culture + mycoplasma/chlamydia testing.
- Lifestyle Intervention 3-6 Months Before Treatment: The sperm production cycle is approximately 72-90 days. Quitting smoking, abstaining from alcohol, avoiding high-temperature environments (saunas, prolonged sitting), and supplementing with folic acid, zinc, and selenium can significantly improve sperm DNA quality.
- Backup Plan for Testicular Sperm Extraction: For patients with extremely severe asthenozoospermia or no motile sperm in the ejaculate, it is advisable to assess in advance whether testicular/epididymal sperm aspiration (TESA/PESA) is needed to avoid the predicament of having no sperm available on the day of egg retrieval.
===== Module I: Actual Procedure =====
6. Actual Procedure: Standard Steps for IVF for Asthenozoospermia
Undergoing IVF for asthenozoospermia in China involves a complete process divided into the following seven stages:
1. Pre-operative Examinations (Approximately 1-2 weeks)
Both partners need to complete these. Male: Semen analysis (including DFI), infectious disease screening, karyotype, Y chromosome microdeletion, reproductive hormones, reproductive tract infection screening. Female: AMH, sex hormone panel (day 2-4), antral follicle count, infectious diseases, thyroid function, hysteroscopy (if necessary).
2. File Creation and Protocol Formulation
Bring your ID card, marriage certificate, passport (for foreign patients), and all examination reports to the reproductive center to create a medical file. The doctor will formulate an ovarian stimulation protocol (long protocol, antagonist protocol, or mild stimulation protocol) based on the female's age, ovarian function, and the male's sperm condition.
3. Ovarian Stimulation (Approximately 10-14 days)
The female receives daily injections of gonadotropins, with regular monitoring of follicle development and hormone levels. When the follicles reach a diameter of 18-22 mm, hCG or a GnRH agonist is administered to trigger ovulation.
4. Egg Retrieval and Sperm Collection (Same Day)
Eggs are retrieved via transvaginal ultrasound-guided puncture of the posterior fornix. The procedure takes about 15-25 minutes and is performed under intravenous anesthesia. The male provides a semen sample via masturbation on the same day. If no usable sperm are found in the ejaculate, TESA/PESA is performed.
5. ICSI Fertilization
In the laboratory, an embryologist selects a single sperm with the best morphology and motility under a microscope and injects it into the oocyte cytoplasm using a microneedle. Fertilization is typically assessed 16-18 hours after injection.
6. Embryo Culture (3-6 days)
Fertilized eggs are cultured in specialized media until day 3 (cleavage stage) or day 5-6 (blastocyst stage). Based on embryo quality and quantity, a decision is made on whether to perform PGT.
7. Transfer and Luteal Support
1-2 high-quality embryos are selected for transfer into the uterine cavity. Remaining embryos can be cryopreserved. A blood test for hCG is performed 12-14 days after transfer to confirm pregnancy. Luteal support continues until approximately 12 weeks of gestation.
===== Module J: Timeline =====
7. Timeline: How Long Does It Take from Initial Consultation to Pregnancy Test
| Stage | Time Required | Notes |
|---|---|---|
| Pre-operative Exams + File Creation | 1-2 weeks | Special tests like karyotype take 10-14 days for results |
| Ovarian Stimulation | 10-14 days | Requires daily injections + 3-5 ultrasound monitoring sessions |
| Egg Retrieval + ICSI + Embryo Culture | 5-6 days | If PGT is performed, an additional 2-4 weeks is needed |
| Transfer + Luteal Support | 12-14 days | Waiting period after transfer for pregnancy test |
| Total Complete Cycle | Approximately 2-3 months | Excludes embryo freezing or subsequent frozen transfers |
For patients traveling from abroad to China, it is recommended to plan for a continuous stay of at least 3-4 weeks (ovarian stimulation + egg retrieval + transfer) or to complete the process in two visits (first visit: stimulation, retrieval, and embryo freezing; second visit: scheduled frozen embryo transfer).
===== Module L: Interpretation of Test Indicators =====
8. Interpretation of Test Indicators: Key Items to Understand on a Semen Analysis Report
Patients with asthenozoospermia should pay special attention to the following five indicators:
| Indicator | Reference Value (WHO 5th Edition) | Clinical Significance |
|---|---|---|
| Sperm Concentration | ≥ 15 million/mL | < 15 indicates oligozoospermia, < 5 indicates severe oligozoospermia |
| Progressive Motility (PR) | ≥ 32% | < 32% indicates asthenozoospermia, < 10% indicates severe asthenozoospermia |
| Normal Morphology Rate | ≥ 4% | < 4% indicates teratozoospermia, ICSI can still be attempted |
| Sperm DNA Fragmentation Rate (DFI) | < 15% normal, 15-30% borderline, > 30% abnormal | Elevated DFI significantly reduces ICSI embryo implantation rate |
| Semen Leukocytes | < 1 million/mL | Elevated levels suggest reproductive tract infection, requiring anti-inflammatory treatment |
It is important to note that results from a single semen analysis can vary significantly. It is recommended to have 2-3 tests (with intervals of 2-4 weeks) and use the average value as the basis for evaluation.
===== Module Q: Frequently Asked Questions =====
9. Frequently Asked Questions
Q1: What sperm standards are needed for IVF with asthenozoospermia?
Theoretically, as long as a single viable sperm with normal morphology and intact DNA can be found in the semen or testis, ICSI can be attempted. However, clinically, it is recommended to have DFI ≤ 30% and sperm concentration ≥ 1 million/mL (to facilitate selection).
Q2: How does the success rate of IVF for asthenozoospermia compare to that for normal sperm?
Under the premise that the female is ≤ 35 years old with normal ovarian function, the live birth rate for ICSI with asthenozoospermia (normal DFI) is approximately 40%-50%, which is 5%-10% lower than for those with normal sperm. However, if DFI is elevated, the live birth rate may drop below 20%.
Q3: How far in advance should I prepare for coming to China for IVF?
It is recommended to start male lifestyle intervention 3-6 months in advance, complete all pre-operative examinations 2 months in advance, and schedule an appointment for file creation 1 month in advance. Documents (ID card, marriage certificate, passport) need to be notarized or translated in advance if required.
Q4: Is PGT necessary for IVF with asthenozoospermia?
Asthenozoospermia itself is not an absolute indication for PGT. However, if it is combined with chromosomal abnormalities, recurrent miscarriage, or advanced maternal age, PGT-A (aneuploidy screening) may be considered. Currently, China has strict indications for PGT, which requires approval from an ethics committee.
Q5: Does the male partner need to be involved throughout the entire process?
The male partner must be present on the day of egg retrieval to provide a sperm sample. For the rest of the time (ovarian stimulation, transfer, etc.), the male partner is not required to accompany, but participation in key steps (file creation, transfer day) is recommended.
===== End: Risk Reminder =====
Notes
Comments (0)